Skip to Main content Skip to Navigation
Journal articles

Combinatorial immunotherapy strategies: most gods throw dice, but fate

Abstract : Immuno-oncology drugs (IODs) are considered as game-changing treatments in oncology, because diseases with once dismal prognosis such as metastatic melanoma or lung cancer now show 3-year survival rates in the 20-40% range. However, it has to be kept in mind
Complete list of metadata

https://hal.inria.fr/hal-03147132
Contributor : Sebastien Benzekry Connect in order to contact the contributor
Submitted on : Friday, February 19, 2021 - 3:49:51 PM
Last modification on : Saturday, December 4, 2021 - 3:44:01 AM
Long-term archiving on: : Thursday, May 20, 2021 - 7:47:53 PM

File

published_online_first.pdf
Files produced by the author(s)

Identifiers

Citation

Joseph Ciccolini, Dominique Barbolosi, Nicolas André, Sebastien Benzekry, Fabrice Barlesi. Combinatorial immunotherapy strategies: most gods throw dice, but fate. Annals of Oncology, Elsevier, 2019, 30 (11), pp.1690-1691. ⟨10.1093/annonc/mdz297/5559268⟩. ⟨hal-03147132⟩

Share

Metrics

Les métriques sont temporairement indisponibles